|Committee Member||Employment||Consultant||Speakers Bureau||Ownership/Partnership/Principal||Personal Research||Institutional, Organizational, or Other Financial Benefit||Expert Witness|
|Patrick T. O’Gara (Chair)||Harvard Medical School—Professor of Medicine; Brigham and Women’s Hospital—Director, Clinical Cardiology||None||None||None||None||None||None|
|Vinay Badhwar (Vice-Chair)||West Virginia University—Gordon F. Murray Professor and Chair, Department of Cardiovascular & Thoracic Surgery; Executive Chair, WVU Heart & Vascular Institute||None||None||None||None||None|
|Paul A. Grayburn (Vice-Chair)||Baylor Heart and Vascular Institute—Director, Cardiology Research||None||None||None|
|Luis C. Afonso||Wayne State University—Professor of Medicine, Division of Cardiology||None||None||None||None||None||None|
|John D. Carroll||University of Colorado Denver—Professor of Medicine; Director, Interventional Cardiology||None||None||None||None|
|Sammy Elmariah||Massachusetts General Hospital—Cardiologist, Department of Medicine||None||None||None||None||None||None|
|Aaron P. Kithcart||Brigham and Women’s Hospital—Cardiovascular Disease Fellow, Division of Cardiovascular Medicine||None||None||None||None||None||None|
|Rick A. Nishimura||Mayo Clinic—Judd and Mary Morris Leighton Professor of Medicine, Division of Cardiovascular Disease||None||None||None||None||None||None|
|Thomas J. Ryan||Ohio State Heart and Vascular Center—Director; Ross Heart Hospital—John G. and Jeanne Bonnet McCoy Chair in Cardiovascular Medicine||None||None||None||None||None|
|Allan Schwartz||Columbia University—Chief, Division of Cardiology||None||None||None||None||None||None|
|Lynn Warner Stevenson||Brigham and Women’s Hospital—Director, Cardiomyopathy and Heart Failure Program||None||None||None||None|
This table represents the relationships of committee members with industry and other entities that were determined to be relevant to this document. These relationships were reviewed and updated in conjunction with all meetings and/or conference calls of the writing committee during the document development process. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of ≥5% of the voting stock or share of the business entity, or ownership of ≥$5,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted. Please refer to http://www.acc.org/guidelines/about-guidelines-and-clinical-documents/relationships-with-industry-policy for definitions of disclosure categories or additional information about the ACC Disclosure Policy for Writing Committees.
ACC = American College of Cardiology; DSMB = data safety monitoring board.